Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients
- 16 April 2007
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 39 (12) , 775-781
- https://doi.org/10.1038/sj.bmt.1705677
Abstract
The incidence of Gram-negative bacteremia has increased in hematopoietic stem cell transplant (HSCT) recipients. We prospectively collected data from 13 Brazilian HSCT centers to characterize the epidemiology of bacteremia occurring early post transplant, and to identify factors associated with infection due to multi-drug-resistant (MDR) Gram-negative isolates. MDR was defined as an isolate with resistance to at least two of the following: third- or fourth-generation cephalosporins, carbapenems or piperacillin-tazobactam. Among 411 HSCT, fever occurred in 333, and 91 developed bacteremia (118 isolates): 47% owing to Gram-positive, 37% owing to Gram-negative, and 16% caused by Gram-positive and Gram-negative bacteria. Pseudomonas aeruginosa (22%), Klebsiella pneumoniae (19%) and Escherichia coli (17%) accounted for the majority of Gram-negative isolates, and 37% were MDR. These isolates were recovered from 20 patients, representing 5% of all 411 HSCT and 22% of the episodes with bacteremia. By multivariate analysis, treatment with third-generation cephalosporins (odds ratio (OR) 10.65, 95% confidence interval (CI) 3.75–30.27) and being at one of the hospitals (OR 9.47, 95% CI 2.60–34.40) were associated with infection due to MDR Gram-negative isolates. These findings may have important clinical implications in the decision of giving prophylaxis and selecting the empiric antibiotic regimen.Keywords
This publication has 28 references indexed in Scilit:
- Antimicrobial susceptibility of Gram-negative bacteria in Brazilian hospitals: the MYSTIC Program Brazil 2003The Brazilian Journal of Infectious Diseases, 2005
- Dissemination in distinct Brazilian regions of an epidemiccarbapenem-resistant Pseudomonas aeruginosa producing SPM metallo- -lactamaseJournal of Antimicrobial Chemotherapy, 2003
- Current Trends in the Epidemiology of Nosocomial Bloodstream Infections in Patients with Hematological Malignancies and Solid Neoplasms in Hospitals in the United StatesClinical Infectious Diseases, 2003
- Bacterial Resistance: Origins, Epidemiology, and ImpactClinical Infectious Diseases, 2003
- Treatment of febrile neutropenia: what is new?Current Opinion in Infectious Diseases, 2002
- Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institutionEuropean Journal Of Cancer, 2001
- Evolution, Incidence, and Susceptibility of Bacterial Bloodstream Isolates from 519 Bone Marrow Transplant PatientsClinical Infectious Diseases, 2001
- Economic justification of antimicrobial management programs: implications of antimicrobial resistanceAmerican Journal of Health-System Pharmacy, 2000
- ANTIMICROBIAL RESISTANCE IN INTENSIVE CARE UNITSClinics in Chest Medicine, 1999
- Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infectionBone Marrow Transplantation, 1998